Stockscreener 앱 받기
24.40
1.66%
0.3985
시간 외 거래:
24.40
0.0015
+0.01%
전일 마감가:
$24.00
열려 있는:
$24.3
하루 거래량:
1,355
Relative Volume:
0.23
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.03%
1개월 성능:
+5.44%
6개월 성능:
+7.65%
1년 성능:
+9.53%
1일 변동 폭
$24.30
$24.60
1주일 범위
$24.00
$24.78
52주 변동 폭
$20.25
$27.44
Lifemd Inc Stock (LFMDP) Company Profile
명칭
Lifemd Inc
전화
866 351 5907
주소
236 Fifth Avenue, Suite 400, New York
LFMDP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFMDP
Lifemd Inc
|
24.40 | 0 | 0 | 0 | 0 | 0.00 |
|
WBA
Walgreens Boots Alliance Inc
|
11.37 | 9.50B | 147.66B | -8.64B | -363.00M | -10.01 |
|
WGRX
Wellgistics Health Inc
|
2.10 | 326.25M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.29 | 191.82M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
3.92 | 73.12M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
SCNX
Scienture Holdings Inc
|
0.895 | 11.39M | 0 | 0 | 0 | 0.00 |
Lifemd Inc 주식(LFMDP)의 최신 뉴스
Wells Fargo & Company MN Boosts Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
LifeMD, Inc. to Participate in Upcoming Investor Conferences in May 2025 - Nasdaq
LifeMD to Participate in Three Investor Conferences During May - GlobeNewswire
LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Barclays PLC - Defense World
HC Wainwright Issues Negative Forecast for LifeMD Earnings - Defense World
LifeMD raises 2025 revenue guidance to $275M driven by telehealth growth - MSN
Mariner LLC Invests $67,000 in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
LFMD Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds LifeMD, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm - ACCESS Newswire
Raymond James Financial Inc. Takes Position in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
LifeMD Might Run Higher (NASDAQ:LFMD) - Seeking Alpha
LifeMD, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates - simplywall.st
Trading (LFMD) With Integrated Risk Controls - news.stocktradersdaily.com
(LFMDP) Investment Report - news.stocktradersdaily.com
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 By Investing.com - Investing.com Nigeria
LifeMD’s Earnings Call: Positive Growth and Strategic Expansion - TipRanks
Cantor Fitzgerald maintains Overweight on LifeMD shares, target $15.00 - Investing.com Australia
BTIG maintains Buy rating, $12 target on LifeMD shares By Investing.com - Investing.com Nigeria
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 50% Yet They're Still Not Telling The Full Story - simplywall.st
LifeMD, Inc. (NASDAQ:LFMD) Q1 2025 Earnings Call Transcript - Insider Monkey
BTIG maintains Buy rating, $12 target on LifeMD shares - Investing.com
LifeMD (LFMD) Exceeds Q1 Expectations and Raises 2025 Outlook - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD earnings beat by $0.07, revenue topped estimates - Investing.com Canada
LifeMD Inc (LFMD) Q1 2025 Earnings Call Highlights: Strong Telehealth Growth and Strategic Partnerships Propel Financial Success - GuruFocus
LifeMD (LFMD) Reports Strong Q1 2025 Performance and Raises Guid - GuruFocus
LifeMD Inc Reports Q1 2025 Earnings: EPS of $0.01 Beats Estimates, Revenue Surges to $65.7 Million - GuruFocus
LifeMD Inc reports results for the quarter ended March 31Earnings Summary - TradingView
LifeMD (LFMD) Sees High Call Activity Ahead of Earnings | LFMD S - GuruFocus
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Earnings call transcript: LifeMD Q1 2025 earnings beat expectations, stock rises - Investing.com
LifeMD (LFMD) Boosts FY25 Revenue and EBITDA Forecasts | LFMD Stock News - GuruFocus
LifeMD (LFMD) Surpasses Revenue Expectations with Strong Q1 Performance | LFMD Stock News - GuruFocus
LifeMD, Inc. SEC 10-Q Report - TradingView
LifeMD, Inc. Reports 49% Revenue Growth and First-Ever Positive GAAP EPS in Q1 2025 Financial Results - Nasdaq
LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance - GlobeNewswire
LifeMD Crushes Q1 Expectations: 70% Telehealth Surge and Historic Profit Milestone - Stock Titan
LifeMD, Inc. Reports Strong Q1 2025 Results - TipRanks
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expec - GuruFocus
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
LifeMD’s (LFMD) “Buy” Rating Reiterated at HC Wainwright - Defense World
LifeMD, Inc. (NASDAQ:LFMD) Shares Sold by JPMorgan Chase & Co. - Defense World
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD Inc expected to post a loss of 5 cents a shareEarnings Preview - TradingView
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD, Inc. (NASDAQ:LFMD) Shares Sold by LPL Financial LLC - Defense World
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
LifeMD (LFMD) Forecasts Robust Earnings Growth Amid Expansion - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Lifemd Inc (LFMDP) 재무 분석
Lifemd Inc (LFMDP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.27%
5.38%
자본화:
|
볼륨(24시간):